Yap, Rodel C.
HRN: 25-30-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2024
CEFUROXIME 1.5GM (VIAL)
06/16/2024
06/23/2024
IV
1.5 Grams
Q8H
Lacerated Wound Chin Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes